Skip to main content
    B

    Baxter International Inc (BAX)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

    $25.75
    +0.95 (+3.83%)

    Market Cap: $12.82B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    82%(32/39)
    Avg Surprise
    +6.47%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.52
    Range$0.50 - $0.54
    12 analysts
    EPS Revisions
    1
    0
    7d
    2
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$0.53-2.6%
    60d ago$0.52+0.0%
    30d ago$0.52-0.2%
    7d ago$0.52-0.2%
    Current$0.52
    Revenue Consensus
    $2.9B
    Range$2.9B - $2.9B
    11 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.85
    Range$0.77 - $0.89
    14 analysts
    Revenue Consensus
    $3.3B
    Range$3.3B - $3.3B
    12 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.85---
    Sep 26EST
    		-$0.52---
    Jun 26
    Reported Jul 30
    		$0.56$0.36+55.56%Beat-5.1%
    Mar 26
    Reported Apr 30
    		$0.36$0.31+16.13%Beat-34.5%
    Dec 25
    Reported Feb 12
    		$0.44$0.54-18.52%Miss-24.1%
    Sep 25
    Reported Oct 30
    		$0.69$0.60+15.00%Beat+40.8%
    Jun 25
    Reported Jul 31
    		$0.59$0.61-3.28%Miss-13.2%
    Mar 25
    Reported May 1
    		$0.55$0.48+14.58%Beat-15.4%
    Dec 24
    Reported Feb 20
    		$0.58$0.52+11.54%Beat-34.1%
    Sep 24
    Reported Nov 8
    		$0.49$0.78-37.18%Miss-27.9%
    Jun 24
    Reported Aug 6
    		$0.68$0.66+3.03%Beat+23.6%
    Mar 24
    Reported May 2
    		$0.65$0.61+6.56%Beat+10.2%
    Dec 23
    Reported Feb 8
    		$0.88$0.86+2.33%Beat+0.0%
    Sep 23
    Reported Nov 2
    		$0.68$0.68+0.00%Beat-17.1%
    Jun 23
    Reported Jul 27
    		$0.55$0.60-8.33%Miss-36.8%
    Mar 23
    Reported Apr 27
    		$0.59$0.49+20.41%Beat-36.6%
    Dec 22
    Reported Feb 9
    		$0.88$0.94-6.38%Miss-15.4%
    Sep 22
    Reported Oct 27
    		$0.82$0.81+1.23%Beat-19.6%
    Jun 22
    Reported Jul 28
    		$0.87$0.87+0.00%Beat+8.7%
    Mar 22
    Reported Apr 28
    		$0.93$0.81+14.81%Beat+22.4%
    Dec 21
    Reported Feb 17
    		$1.04$1.03+0.97%Beat+30.0%
    Sep 21
    Reported Oct 28
    		$1.02$0.94+8.51%Beat+22.9%
    Jun 21
    Reported Jul 29
    		$0.80$0.75+6.67%Beat+25.0%
    Mar 21
    Reported Apr 29
    		$0.76$0.65+16.92%Beat-7.3%
    Dec 20
    Reported Feb 4
    		$0.80$0.76+5.26%Beat-17.5%
    Sep 20
    Reported Oct 29
    		$0.83$0.72+15.28%Beat+12.2%
    Jun 20
    Reported Jul 30
    		$0.64$0.71-9.86%Miss-28.1%
    Mar 20
    Reported Apr 30
    		$0.82$0.72+13.89%Beat+7.9%
    Dec 19
    Reported Mar 17
    		$0.97$0.88+10.23%Beat+24.4%
    Sep 19
    Reported Oct 24
    		$0.74$0.84-11.90%Miss-7.5%
    Jun 19
    Reported Jul 25
    		$0.89$0.81+9.88%Beat+15.6%
    Mar 19
    Reported Apr 25
    		$0.76$0.68+11.76%Beat+8.6%
    Dec 18
    Reported Jan 31
    		$0.78$0.73+6.85%Beat+21.9%
    Sep 18
    Reported Oct 31
    		$0.80$0.74+8.11%Beat+25.0%
    Jun 18
    Reported Jul 26
    		$0.77$0.71+8.45%Beat+22.2%
    Mar 18
    Reported Apr 26
    		$0.70$0.62+12.90%Beat+20.7%
    Dec 17
    Reported Feb 1
    		$0.64$0.59+8.47%Beat+12.3%
    Sep 17
    Reported Oct 25
    		$0.64$0.59+8.47%Beat-
    Jun 17
    Reported Jul 26
    		$0.63$0.57+10.53%Beat-
    Mar 17
    Reported Apr 26
    		$0.58$0.51+13.73%Beat-
    Dec 16
    Reported Feb 1
    		$0.57$0.52+9.62%Beat-

    Dividends

    Dividend Metrics

    Forward Yield0.16%
    Forward Annual Dividend$0.04
    Payout Ratio1.57%
    FrequencyQuarterly
    Pay MonthsJan, Apr, Jul, Oct

    Growth

    3Y CAGR-23.25%
    5Y CAGR-11.45%
    BAX dividend history and ex-dividend datesRun BAX in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio12.56EV/EBITDA28.80x
    Price/FCF16.33xFCF Yield6.12%
    Profitability
    Profit Margin-9.27%Operating Margin14.40%
    ROE-14.40%ROIC-1.51%
    Financial Health
    Debt/Equity1.52xInterest CoverageN/A
    Current Ratio1.95xQuick Ratio1.32x
    Trading Statistics
    Beta0.65Avg Volume6.93M
    52-Week High$29.9952-Week Low$15.72

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$24.45
    SMA 20$23.94
    SMA 50$25.04
    SMA 200$21.06
    EMA 10$24.60
    EMA 20$24.37
    EMA 50$24.25
    EMA 200$22.55

    MACD

    Line: 0.15Signal: -0.11Hist: 0.25

    ADX

    ADX: 21.8+DI: 31.1-DI: 10.7

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down28.0
    PSAR$24.00

    Bollinger Bands

    Upper Band$25.39
    Lower Band$22.50
    %B Position1205%(Upper)
    Band Width1.13

    RSI (14-Day)

    Neutral
    66.0

    Momentum Oscillators

    Stoch %K85.5
    Stoch %D86.2
    Williams %R-4.9
    ROC (10d)8.9%
    Momentum2.11
    CCI (20d)220.9
    MFI (14d)57.0

    Volatility Measures

    ATR (14d)$0.71(2.7%)
    StdDev (20d)0.72
    Hist Vol25.3%(Moderate)

    Volume Flow

    VWAP$25.62
    OBV70.5M
    AD Line-576.1M
    CMF (20d)0.105

    Volume Metrics

    Avg Vol (20d)6.8M
    Vol Ratio0.7x
    VWMA (20d)$23.80

    Pivot Points

    R3$25.49
    R2$25.26
    R1$25.03
    Pivot Point$24.81
    S1$24.58
    S2$24.35
    S3$24.12

    Advanced Oscillators

    TSI6.18
    Ultimate Osc61.2
    KST-15.42

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.96B$2.70B$2.97B$2.83B$2.81B$2.63B$2.75B$2.70B$2.69B$2.49B$541.00M$2.60B
    Cost of Revenue$1.93B$1.81B$2.40B$1.89B$1.82B$1.76B$1.79B$1.67B$1.66B$1.53B$-167,000,000$1.54B
    Gross Profit$1.03B$891.00M$577.00M$950.00M$991.00M$861.00M$959.00M$1.03B$1.03B$961.00M$708.00M$1.06B
    Operating Expenses$815.00M$825.00M$1.31B$778.00M$800.00M$803.00M$1.39B$878.00M$852.00M$846.00M$292.00M$877.00M
    R&D$129.00M$139.00M$126.00M$118.00M$134.00M$140.00M$211.00M$129.00M$130.00M$120.00M$56.00M$133.00M
    SG&A$735.00M$728.00M$761.00M$708.00M$718.00M$703.00M$761.00M$754.00M$723.00M$729.00M$250.00M$744.00M
    Operating Income$217.00M$66.00M$-729,000,000$172.00M$191.00M$58.00M$-435,000,000$155.00M$179.00M$115.00M$416.00M$179.00M
    Interest Income$-64,000,000$-66,000,000$-58,000,000$-58,000,000$-58,000,000$-64,000,000$-90,000,000$-87,000,000$-86,000,000$-78,000,000$0$-127,000,000
    Interest Expense$59.00M$72.00M$27.00M$51.00M$58.00M$61.00M$86.00M$86.00M$62.00M$69.00M$69.00M$115.00M
    Income Before Tax$158.00M$-6,000,000$-756,000,000$121.00M$133.00M$-3,000,000$-521,000,000$69.00M$117.00M$46.00M$347.00M$64.00M
    Income Tax Expense$23.00M$11.00M$279.00M$172.00M$11.00M$-67,000,000$-33,000,000$8.00M$22.00M$40.00M$10.00M$27.00M
    Net Income$126.00M$-15,000,000$-1,128,000,000$-46,000,000$91.00M$126.00M$-510,000,000$144.00M$-311,000,000$39.00M$246.00M$2.51B
    EBITDA$461.00M$297.00M$-458,000,000$416.00M$448.00M$308.00M$-186,000,000$410.00M$430.00M$395.00M$682.00M$283.00M
    EBIT$222.00M$60.00M$-698,000,000$179.00M$191.00M$61.00M$-431,000,000$156.00M$203.00M$124.00M$418.00M$191.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BAX

    News

    BAXTER INTERNATIONAL INC. R (BTL.DU) Q1 FY2026 earnings call transcript

    Baxter International reported Q1 2026 sales of $2.7 billion, showing a 3% year-over-year increase but a 1% organic decline...

    Yahoo Finance•10/15/26•Somewhat-Bearish

    BAXTER INTERNATIONAL INC. R (BTL.DU) Q1 FY2026 earnings call transcript

    Baxter International reported Q1 2026 sales of $2.7 billion, showing a 3% year-over-year increase but a 1% organic decline, with adjusted EPS at $0.36...

    Yahoo Finance•10/15/26•Neutral

    Baxter International Inc (BAX) Shares Surge 3.9% -- What GF Scor

    Baxter International Inc (BAX) shares surged 3.9% to $25.76, placing its GF Score™ at 71/100, categorizing it as above average. Despite being deemed undervalued with a GF Value™ of $31.72...

    GuruFocus•10/15/26•Somewhat-Bullish

    How organizations prepare their supply chains for the next crisis

    Executives from Advocate Health, Baxter International, and Vizient will participate in a Modern Healthcare webinar on October 22. The webinar will focus on strategies for healthcare companies to strengthen their supply...

    Modern Healthcare•10/15/26•Somewhat-Bullish

    Firing on All Cylinders: Baxter (NYSE:BAX) Q2 Earnings Lead the Way

    Baxter (NYSE:BAX) reported strong Q2 earnings, exceeding revenue and EPS estimates, positioning it as a top performer in the diversified medical devices & supplies industry. While the sector as a whole faced headwinds...

    TradingView•10/14/26•Neutral

    BAX Valuation and Fair Value

    P/E
    12.6x
    Forward P/E
    11.6x
    EV/EBITDA
    28.8x
    P/FCF
    16.3x
    PEG
    36.7x
    P/B
    2.1x
    See GNG's fair value

    BAX Profitability: Margins, ROIC and FCF

    Gross margin
    30.1%
    Operating margin
    14.4%
    Net margin
    -9.3%
    ROIC
    -1.5%
    ROE
    -14.4%
    FCF margin
    7.1%
    FCF yield
    6.1%

    BAX Competitors

    CompanyTicker
    Summit Therapeutics PLCSMMT
    BridgeBio Pharma IncBBIO
    ICON PLCICLR
    Penumbra IncPEN
    Halozyme Therapeutics IncHALO
    BrightSpring Health Services, Inc. Common StockBTSG
    Jazz Pharmaceuticals PLCJAZZ
    Encompass Health CorpEHC

    Sector: Healthcare

    BAX Analyst Ratings

    Consensus
    Hold
    Analysts
    13
    Strong Buy
    0
    Buy
    2
    Hold
    11
    Sell
    0
    Strong Sell
    0

    BAX Bull Case vs Bear Case

    Bear case

    • BAX has a -9.3% net profit margin.

    BAX Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    6.7%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.52
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 7 down

    BAX Dividend

    Forward yield
    0.2%
    Payout ratio
    1.6%
    3Y DPS growth
    -23.2%
    5Y DPS growth
    -11.4%
    Pay months
    Jan, Apr, Jul, Oct
    BAX dividend history

    Frequently Asked Questions About BAX

    What is BAX's current dividend yield?

    Baxter International Inc (BAX) has a forward dividend yield of 0.16%.

    Does BAX pay dividends?

    Yes, Baxter International Inc pays dividends with a forward dividend yield of 0.16%.

    What is BAX's P/E ratio?

    Baxter International Inc has a price-to-earnings (P/E) ratio of 12.56.

    What is BAX's market cap?

    Baxter International Inc (BAX) has a market capitalization of $12.82B with a current stock price of $25.75.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In